Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 980345, 8 pages
http://dx.doi.org/10.1155/2015/980345
Research Article

Deepure Tea Improves High Fat Diet-Induced Insulin Resistance and Nonalcoholic Fatty Liver Disease

1Tasly Microcirculation Research Center, Peking University Health Science Center, Beijing 100191, China
2Key Laboratory of Microcirculation, State Administration of Traditional Chinese Medicine of the People’s Republic of China, Beijing 100191, China
3Key Laboratory of Stasis and Phlegm, State Administration of Traditional Chinese Medicine of the People’s Republic of China, Beijing 100191, China
4Institute of Materia Medica, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100050, China
5Department of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Peking University, Beijing 100191, China

Received 26 March 2015; Revised 24 June 2015; Accepted 25 June 2015

Academic Editor: Akhilesh K. Tamrakar

Copyright © 2015 Jing-Na Deng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. G. M. M. Alberti and P. Z. Zimmet, “Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation,” Diabetic Medicine, vol. 15, no. 7, pp. 539–553, 1998. View at Google Scholar · View at Scopus
  2. J. D. Browning and J. D. Horton, “Molecular mediators of hepatic steatosis and liver injury,” The Journal of Clinical Investigation, vol. 114, no. 2, pp. 147–152, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Marchesini, M. Brizi, G. Blanchi et al., “Nonalcoholic fatty liver disease: a feature of the metabolic syndrome,” Diabetes, vol. 50, no. 8, pp. 1844–1850, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. H. C. Masuoka and N. Chalasani, “Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals,” Annals of the New York Academy of Sciences, vol. 1281, no. 1, pp. 106–122, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. V. Ratziu and T. Poynard, “Assessing the outcome of nonalcoholic steatohepatitis? It's time to get serious,” Hepatology, vol. 44, no. 4, pp. 802–805, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Kotronen and H. Yki-Järvinen, “Fatty liver: a novel component of the metabolic syndrome,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 1, pp. 27–38, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Haentjens, D. Massaad, H. Reynaert et al., “Identifying non-alcoholic fatty liver disease among asymptomatic overweight and obese individuals by clinical and biochemical characteristics,” Acta Clinica Belgica, vol. 64, no. 6, pp. 483–493, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Kido, D. J. Burks, D. Withers et al., “Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2,” The Journal of Clinical Investigation, vol. 105, no. 2, pp. 199–205, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. D. J. Withers, J. S. Gutierrez, H. Towery et al., “Disruption of IRS-2 causes type 2 diabetes in mice,” Nature, vol. 391, no. 6670, pp. 900–904, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Shimomura, Y. Bashmakov, S. Ikemoto, J. D. Horton, M. S. Brown, and J. L. Goldstein, “Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 24, pp. 13656–13661, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. V. T. Samuel, Z.-X. Liu, X. Qu et al., “Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease,” Journal of Biological Chemistry, vol. 279, no. 31, pp. 32345–32353, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Ide, H. Shimano, N. Yahagi et al., “SREBPs suppress IRS-2-mediated insulin signalling in the liver,” Nature Cell Biology, vol. 6, no. 4, pp. 351–357, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. M. den Boer, P. J. Voshol, F. Kuipers, L. M. Havekes, and J. A. Romijn, “Hepatic steatosis: a mediator of the metabolic syndrome. Lessons from animal models,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 4, pp. 644–649, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. C. A. Nagle, E. L. Klett, and R. A. Coleman, “Hepatic triacylglycerol accumulation and insulin resistance,” Journal of Lipid Research, vol. 50, supplement, pp. S74–S79, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Cabrera, R. Artacho, and R. Giménez, “Beneficial effects of green tea—a review,” Journal of the American College of Nutrition, vol. 25, no. 2, pp. 79–99, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Kubota, S. Sumi, H. Tojo et al., “Improvements of mean body mass index and body weight in preobese and overweight Japanese adults with black Chinese tea (Pu-Erh) water extract,” Nutrition Research, vol. 31, no. 6, pp. 421–428, 2011. View at Google Scholar
  17. Z.-H. Cao, D.-H. Gu, Q.-Y. Lin et al., “Effect of pu-erh tea on body fat and lipid profiles in rats with diet-induced obesity,” Phytotherapy Research, vol. 25, no. 2, pp. 234–238, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Shimamura, M. Yoda, H. Sakakibara, K. Matsunaga, and S. Masuda, “Pu-erh tea suppresses diet-induced body fat accumulation in C57BL/6J mice by down-regulating SREBP-1c and related molecules,” Bioscience, Biotechnology and Biochemistry, vol. 77, no. 7, pp. 1455–1460, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. X. Ma, S. Tsuda, X. Yang et al., “Pu-erh tea hot-water extract activates akt and induces insulin-independent glucose transport in rat skeletal muscle,” Journal of Medicinal Food, vol. 16, no. 3, pp. 259–262, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Wang, S. K. Noh, and S. I. Koo, “Epigallocatechin gallate and caffeine differentially inhibit the intestinal absorption of cholesterol and fat in ovariectomized rats,” The Journal of Nutrition, vol. 136, no. 11, pp. 2791–2796, 2006. View at Google Scholar · View at Scopus
  21. D. G. Raederstorff, M. F. Schlachter, V. Elste, and P. Weber, “Effect of EGCG on lipid absorption and plasma lipid levels in rats,” Journal of Nutritional Biochemistry, vol. 14, no. 6, pp. 326–332, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Tao, F. Ye, Y. He et al., “Improvement of high-fat-diet-induced metabolic syndrome by a compound from Balanophora polyandra Griff in mice,” European Journal of Pharmacology, vol. 616, no. 1–3, pp. 328–333, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, “Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Publisher · View at Google Scholar · View at Scopus
  24. S.-Q. Lin, X.-H. Wei, P. Huang et al., “Qi Shen Yi Qi Pills prevents cardiac ischemia-reperfusion injury via energy modulation,” International Journal of Cardiology, vol. 168, no. 2, pp. 967–974, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. X. J. Sun, L.-M. Wang, Y. Zhang et al., “Role of IRS-2 in insulin and cytokine signalling,” Nature, vol. 377, no. 6545, pp. 173–177, 1995. View at Publisher · View at Google Scholar · View at Scopus
  26. J. D. Horton, J. L. Goldstein, and M. S. Brown, “SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver,” Journal of Clinical Investigation, vol. 109, no. 9, pp. 1125–1131, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Han, C.-P. Liang, M. Westerterp et al., “Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice,” Journal of Clinical Investigation, vol. 119, no. 4, pp. 1029–1041, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Streicher, J. Kotzka, D. Müller-Wieland et al., “SREBP-1 mediates activation of the low density lipoprotein receptor promoter by insulin and insulin-like growth factor-I,” The Journal of Biological Chemistry, vol. 271, no. 12, pp. 7128–7133, 1996. View at Publisher · View at Google Scholar · View at Scopus
  29. J. K. Kim, M. D. Michael, S. F. Previs et al., “Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle,” The Journal of Clinical Investigation, vol. 105, no. 12, pp. 1791–1797, 2000. View at Publisher · View at Google Scholar · View at Scopus
  30. G. I. Shulman, “Cellular mechanisms of insulin resistance,” Journal of Clinical Investigation, vol. 106, no. 2, pp. 171–176, 2000. View at Publisher · View at Google Scholar · View at Scopus
  31. M. A. Abdul-Ghani, D. Tripathy, and R. A. DeFronzo, “Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose,” Diabetes Care, vol. 29, no. 5, pp. 1130–1139, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. W.-H. Du, S.-M. Peng, Z.-H. Liu, L. Shi, L.-F. Tan, and X.-Q. Zou, “Hypoglycemic effect of the water extract of Pu-erh tea,” Journal of Agricultural and Food Chemistry, vol. 60, no. 40, pp. 10126–10132, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. I. Shimomura, M. Matsuda, R. E. Hammer, Y. Bashmakov, M. S. Brown, and J. L. Goldstein, “Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice,” Molecular Cell, vol. 6, no. 1, pp. 77–86, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Shimano, N. Yahagi, M. Amemiya-Kudo et al., “Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes,” The Journal of Biological Chemistry, vol. 274, no. 50, pp. 35832–35839, 1999. View at Publisher · View at Google Scholar · View at Scopus
  35. M. S. Brown and J. L. Goldstein, “The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor,” Cell, vol. 89, no. 3, pp. 331–340, 1997. View at Publisher · View at Google Scholar · View at Scopus
  36. J. D. Horton, “Sterol regulatory element-binding proteins: transcriptional activators of lipid synthesis,” Biochemical Society Transactions, vol. 30, no. 6, pp. 1091–1095, 2002. View at Publisher · View at Google Scholar · View at Scopus
  37. H. Gao, Z. Liu, W. Wan, X. Qu, and M. Chen, “Aqueous extract of yerba mate tea lowers atherosclerotic risk factors in a rat hyperlipidemia model,” Phytotherapy Research, vol. 27, no. 8, pp. 1225–1231, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Murase, K. Misawa, Y. Minegishi et al., “Coffee polyphenols suppress diet-induced body fat accumulation by downregulating SREBP-1c and related molecules in C57BL/6J mice,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 300, no. 1, pp. E122–E133, 2011. View at Publisher · View at Google Scholar · View at Scopus